By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
PharmAthene, Inc. (PIP) Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine 9/10/2014 9:17:17 AM
PharmAthene, Inc. (PIP) Release: New Non-Clinical Data Demonstrate SparVax® Provides Equivalent Protection In Head-To-Head Comparison With BioThrax® 9/9/2014 8:17:26 AM
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014 10:52:30 AM
PharmAthene, Inc. (PIP) To Present At Rodman & Renshaw And Aegis Capital Corporation 2014 Investment Conferences 9/8/2014 10:43:14 AM
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014 9:13:10 AM
Delaware Court Of Chancery Orders SIGA Technologies, Inc. (SIGA) To Pay PharmAthene, Inc. (PIP) Lump Sum Expectation Damages 8/11/2014 8:18:48 AM
PharmAthene, Inc. (PIP) Reports Second Quarter 2014 Financial And Operational Results 8/5/2014 7:13:38 AM
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014 11:07:02 AM
PharmAthene, Inc. (PIP) Presents New SparVax® Anthrax Vaccine Data At The FDA Medical Countermeasures Initiative Symposium 6/4/2014 9:38:06 AM
PharmAthene, Inc. (PIP) Presents New SparVax® Anthrax Vaccine Data At The American Society for Microbiology 2014 Meeting 5/29/2014 10:55:26 AM
12345678910...
//-->